Case studies

Case studies are summaries of some of the successful R&D projects that have been funded through one of our programmes in recent years. Read about the societal, environmental and commercial impact of these international collaborations.

Filters

New medical tech

(Eurostars)

Innovation rhymes with collaboration

Rescoll with its Danish partners Biomodics and the Danish Technological Institute developed catheters that prevent bladder infections. With the Spanish Centro Tecnológico Riojano and a large company active in the automotive sector, Rescoll innovated a new type of rubber.

Project funded by: France (bpifrance), Denmark (Innovation fund Denmark), Spain (CDTI)
Participants:
• 
• 
• 
• 

Project funded by: ?
Published: 30/01/2018

  • Biomodics (Denmark – SME)
  • Centro Tecnológico Riojano (Spain – SME)
  • Rescoll (France – SME and lead partner)
  • Danish Technological Institute (Denmark – research organisation)

EMOTIONLAB

(Eurostars)

Show some emotion to learn better

The EmotionLab consortium of Danish and Swedish SMEs and universities created a new technology to detect emotions. They can apply this understanding to develop further cutting-edge adaptive learning solutions to enhance science education and corporate laboratory training.


The modern world is based on scientific and technological innovation, but around two-thirds of science students in Europe drop out of their studies in high school or university. What can be done to engage and retain more young people in science and technology education?


The consortium’s approach was to transform and enlarge the learning environment. This was achieved by using technology creatively developed in interactive virtual learning environments that use gaming elements to drive engagement and understanding.

Project funded by: Innovation Fund Denmark, SERI (Switzerland)

  • Labster (Denmark – SME and lead partner)
  • Learn Technologies (Switzerland – SME)
  • University of Southern Denmark (university)

SORTS

(ITEA3)

Real-time imaging: a vital step for precision medicine

A team of technology and medical specialists created a new system that greatly increases the speed with which medical imagery can be made available, enabling less invasive treatments for diseases such as cancer. MRI scans can take several minutes to produce, during which time the exact position of a cancerous tumour can change, for example if a patient moves slightly. The new system developed by SORTS project partners, including original software, makes MRI-based feedback available within a fraction of a second. Doctors can target treatment using non-invasive therapy systems such as linear accelerators and high-intensity focused ultrasound.

The new real-time, image-guided system is a vital step in the transition from invasive to non-invasive medical intervention. It significantly boosts the precision and effectiveness of treatment, reducing patient risk while increasing throughput. That means shorter hospital stays and lower health costs. The technology has been trialled at 16 university hospitals around the world.

  • Philips Medical Systems Nederland B.v.) (Netherlands – large company and leading role)

Solar CPC PVT Production

(Eurostars)

Scaling up solar energy innovation

A consortium of Swedish, Cypriot and Portuguese organisations powered by Solarus (a Dutch SME with a research centre in Sweden) have tested a unique solar collector (C-PVT) that combines solar photovoltaic electricity generation with solar thermal heat generation. Sunlight lands on an aluminium receiver with solar cells (protected by transparent silicone) on both sides. Then water flows inside the receiver cooling the cells, which gain 5% efficiency for every 10⁰C of temperature reduction. The project also successfully reduced production costs of the solar collector by automating their process and investing in new machinery (a silicone dispenser, solar tower and electroluminescence tester).

The esteem of Eurostars’ rigorous review process attracted venture capital of 6.7 million euro for Solarus and they’re ready to transform the energy market. The solar collectors can be used in energy-consuming industries like food production, hospitality, metal processing and to produce energy and heating in isolated communities.

Funded by RVO, Vinnova, Research Promotion Foundation and Agência Nacional de Inovação

  • Solarus Sunpower Sweden AB (Sweden – SME)

GOLD

(Clusters)

Super-fast broadband at home

A consortium of telecommunications experts brought next-generation broadband closer to market, further developing a new technology known as G.fast. It can deliver high-speed internet access through a mashup of optical fibres and existing copper wires at a fraction of the cost of using all-optical solutions. The roll-out of optical fibre across cities and all the way into individual homes is a massive task. The GOLD project’s solution sees optical fibre neighbourhood distribution points with legacy telephone lines to transmit broadband services the last few metres into homes.

Recent years have witnessed an explosion in demand for video content and file-sharing, and developments to the Internet of Things require ever-increasing bandwidth. G.fast can deliver major cost reductions for consumers of these services, particularly within dense urban areas, as it significantly reduces the installation workload for utility providers and technicians.

  • Lund University (Sweden – university and leading role)

FR-OST

(Eurostars)

Meeting an unmet need: Smarter, safer addiction treatment

UK and Finnish companies and a university have patented a device for controlled dispensing of opioid substitutes for people overcoming heroin addictions. Opioid substitutes minimise withdrawal cravings, but intake must be monitored, as overconsumption or use combined with other drugs is dangerous.

FR-OST project’s prototype has fingerprinting technology for patients to unlock a portable drug dispenser (at pre-set times) only if there are no additional substances in their system and levels of the substitutes are balanced. Patients receive a safe supply of medication each week, allowing regular life at home and giving healthcare providers time to treat the causes of addiction. The device could be repurposed for pain medication and non-invasive drug testing by police.

The prototype will be manufactured and then marketed in Europe and the US with expected revenue for both companies, jobs created and royalties on sales. Project participants say Eurostars was instrumental in obtaining investment.

LDL4HELTA

(Network Projects)

Meaningful relationships shape the semantic web business

The Austrian, Israeli and Spanish participants in the Eureka LDL4HELTA project capitalised on developments in AI, text mining and lexicography to develop new tools and services to meet the growing demand for language technologies.  


A key focus for the project was on “word-sense disambiguation”. This critical language technology identifies a sentence’s meaning when different interpretations are possible. It enables more value to be attached to high-quality information available in linked data form, including knowledge graphs. The semantic web (a more intelligent and intuitive web) is one step closer. 


Eureka helped the SME partners to strengthen their services and deepen their skills and knowledge in the burgeoning language technology market.

Project funded by: FFG (Austria), OCS (Israel)

  • Semantic Web Company (Austria – SME and lead partner)
  • K Dictionaries (Israel – SME)
  • Universidad Politécnica de Madrid (Spain – university)

EYEINJECT

(Network Projects)

Research with a vision

Czech and Slovak project participants developed a new medical device to help people in pain after eye surgery. Patients often experience discomfort when recovering from operations like laser-assisted sub-epithelial keratectomy (LASEK), where surgeons use a laser to reshape the surface of the cornea. There are anaesthetic drops that can help, but they tend to slow down the healing process. Researchers in the Eureka EYEINJECT project wanted to create a device for injecting a painkilling solution straight into the cornea. The needle had to be extremely thin and delicate and the injection very precise to avoid damaging the eye.

The device they developed features a needle with a diameter of just 0.15mm, and it can also be used to administer antibiotics in the case of corneal infections and for corneal cross-linking (a procedure to treat a condition called keratoconus), where the cornea thins out and weakens. Commercial success beckons.

  • Gemini Eye Clinic (Czech Republic – medical clinic and leading role)
  • Augenlaser Praxis Dr Pavel Stodulka (Austria – medical clinic)
  • Tajmac ZPS (Czech Republic – medical clinic )
  • Precision Tubes Europe (Slovakia – technology innovator)